Pharmaceuticals news FT.com

Pfizer to halt development of closely watched weight-lo...

US pharmaceutical group says patient in study ‘experienced potential drug-induce...

NHS signs deal with Scancell in ambitious skin cancer t...

Move comes as government seeks to boost UK’s standing as drugs research leader

Trade war could put the frown back on Botox users’ faces

Fears that pharmaceuticals could yet be hit by tariffs have sent shares sharply ...

Swiss drugmaker Novartis to invest $23bn in US manufact...

Pharma group builds out American supply chains as part of preparations for poten...

UK promises rapid review of NHS drug-pricing rebate

Under the scheme, drugmakers discount the price of medicines sold in bulk to the...

Bling, bags and booze fall victim to Trump’s trade war

US consumers are likely to be hit by the price rises across sectors from aviatio...

Sector by sector: the Trump tariff fallout

US consumers are set to be the biggest victims with cost increases set to be pas...

Brookfield to buy laboratory equipment group Antylia Sc...

Deal is latest sign of the uptick in exits by private equity groups despite slug...

A biotech M&A revival is in the pipeline

Acquisitions hold the cure for pharma companies’ chronic patent cliff problem

Google DeepMind’s drug discovery spin-off Isomorphic La...

AI unit is boosted by first external funding round led by OpenAI-backer Thrive C...

Top US vaccine official resigns over Kennedy’s ‘misinfo...

Peter Marks says ‘truth and transparency are not desired’ by health secretary as...

EU regulator declines approval for Eli Lilly’s new Alzh...

European Medicines Agency says risks of potentially fatal side effects from dona...

Elliott held talks with private equity as it considered...

US hedge fund gauged investor interest in German conglomerate’s consumer health ...

An ominous shadow falls over mRNA technology

Once researchers begin wondering whether their government might pull the rug fro...

How 23andMe’s gene-testing dream turned recessive

The biotech group created a revolutionary technology but it never hit on a susta...

Pensions risk: the downside of weight-loss drugs

The health benefits could be so extreme that it upends the annuity market, hitti...

AstraZeneca to invest $2.5bn in China after scandal

London-listed drugmaker will establish research centre in Beijing

Why a weight-loss drug could become a geopolitical barg...

Ozempic might feature in future US negotiations with Denmark over Greenland

Former UK IPO star Nanopore admits it is a takeover target

DNA sequencing specialist’s decision to list in London in 2021 was seen as a vic...

Women in UK face HRT treatment ‘lottery’, doctors warn

Experts say there are regional disparities in medication access even as prescrip...

Higher medicine sales tax makes UK ‘uninvestable’, warn...

Industry lobby group calls for action from government ahead of summit in April

Higher medicine sales tax makes UK ‘uninvestable’, drug...

Industry lobby group calls for action from government ahead of summit in April

Trump funding cuts will ‘kneecap’ US innovation, univer...

Academic institutions have been forced to freeze new hires and limit PhD places

AstraZeneca buys cell therapy biotech in up to $1bn deal

London-listed pharmaceuticals group expands investments in cancer cell therapies...

This site uses cookies. By continuing to browse the site you are agreeing to our use of cookies.